Roche, Allergan Sue Apotex Again Over Acular Patent
The complaint, filed by Roche Palo Alto LLC and Allergan, was filed shortly after the U.S. Court of Appeals for the Federal Circuit granted Apotex a second chance to seek the invalidation of a patent for Acular.
Apotex filed an abbreviated new drug application with the U.,S. Food and Drug Administration for Acular with...
To view the full article, register now.